FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.330
+0.010 (0.76%)
At close: Apr 1, 2026, 4:00 PM EDT
1.306
-0.024 (-1.80%)
After-hours: Apr 1, 2026, 7:59 PM EDT

FibroBiologics Stock Forecast

FBLG's stock price has decreased by -92.61% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for FibroBiologics stock has a target of 80, which predicts a 5,915.04% increase from the current stock price of 1.33.

Price Target: $80 (+5,915.04%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$80$80$80$80
Change+5915.0%+5915.0%+5915.0%+5915.0%
* Price targets were last updated on Feb 26, 2026.

Analyst Ratings

The average analyst rating for FibroBiologics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingOct '25Nov '25Dec '25Jan '26Feb '26Mar '26
Strong Buy433221
Buy000000
Hold000001
Sell000000
Strong Sell000000
Total433222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
D. Boral Capital
D. Boral Capital
Hold
Downgrades
n/a
HoldDowngradesn/an/aMar 26, 2026
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$140
Strong BuyMaintains$140+10,426.32%Mar 12, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$100$80
Strong BuyMaintains$100$80+5,915.04%Feb 26, 2026
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$300$140
Strong BuyMaintains$300$140+10,426.32%Feb 25, 2026
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$300
Strong BuyMaintains$300+22,456.39%Jan 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.25
from -8.35
EPS Next Year
-0.27
from -0.25
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-3.62-3.63-13.50-6.79-8.35-0.25-0.27
EPS Growth
-------
Forward PE
-------
No. Analysts
-----66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030
High-0.18-0.17
Avg-0.25-0.27
Low-0.28-0.37

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.